GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRadimed Corp (FRA:46K) » Definitions » Cyclically Adjusted PB Ratio

iRadimed (FRA:46K) Cyclically Adjusted PB Ratio : 10.63 (As of Jun. 02, 2025)


View and export this data going back to 2019. Start your Free Trial

What is iRadimed Cyclically Adjusted PB Ratio?

As of today (2025-06-02), iRadimed's current share price is €51.00. iRadimed's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was €4.80. iRadimed's Cyclically Adjusted PB Ratio for today is 10.63.

The historical rank and industry rank for iRadimed's Cyclically Adjusted PB Ratio or its related term are showing as below:

FRA:46K' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 7   Med: 9.85   Max: 12.02
Current: 11.03

During the past years, iRadimed's highest Cyclically Adjusted PB Ratio was 12.02. The lowest was 7.00. And the median was 9.85.

FRA:46K's Cyclically Adjusted PB Ratio is ranked worse than
94.77% of 497 companies
in the Medical Devices & Instruments industry
Industry Median: 1.87 vs FRA:46K: 11.03

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

iRadimed's adjusted book value per share data for the three months ended in Mar. 2025 was €6.551. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €4.80 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


iRadimed Cyclically Adjusted PB Ratio Historical Data

The historical data trend for iRadimed's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRadimed Cyclically Adjusted PB Ratio Chart

iRadimed Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 6.87 10.61 10.83

iRadimed Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.38 9.06 10.12 10.83 9.99

Competitive Comparison of iRadimed's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, iRadimed's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iRadimed's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, iRadimed's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where iRadimed's Cyclically Adjusted PB Ratio falls into.


;
;

iRadimed Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

iRadimed's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=51.00/4.80
=10.63

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

iRadimed's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, iRadimed's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=6.551/134.9266*134.9266
=6.551

Current CPI (Mar. 2025) = 134.9266.

iRadimed Quarterly Data

Book Value per Share CPI Adj_Book
201506 2.037 100.684 2.730
201509 2.263 100.392 3.041
201512 2.623 99.792 3.546
201603 2.406 100.470 3.231
201606 2.375 101.688 3.151
201609 2.549 101.861 3.376
201612 2.819 101.863 3.734
201703 2.786 102.862 3.654
201706 2.632 103.349 3.436
201709 2.555 104.136 3.310
201712 2.626 104.011 3.407
201803 2.614 105.290 3.350
201806 2.903 106.317 3.684
201809 3.142 106.507 3.980
201812 3.355 105.998 4.271
201903 3.546 107.251 4.461
201906 3.727 108.070 4.653
201909 4.113 108.329 5.123
201912 4.247 108.420 5.285
202003 4.389 108.902 5.438
202006 4.249 108.767 5.271
202009 4.201 109.815 5.162
202012 4.100 109.897 5.034
202103 4.304 111.754 5.196
202106 4.374 114.631 5.148
202109 4.676 115.734 5.451
202112 5.092 117.630 5.841
202203 4.522 121.301 5.030
202206 4.963 125.017 5.356
202209 5.608 125.227 6.042
202212 5.524 125.222 5.952
202303 4.771 127.348 5.055
202306 5.054 128.729 5.297
202309 5.544 129.860 5.760
202312 5.173 129.419 5.393
202403 5.530 131.776 5.662
202406 5.842 132.554 5.947
202409 5.933 133.029 6.018
202412 6.523 133.157 6.610
202503 6.551 134.927 6.551

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


iRadimed  (FRA:46K) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


iRadimed Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of iRadimed's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


iRadimed Business Description

Traded in Other Exchanges
Address
1025 Willa Springs Drive, Winter Springs, FL, USA, 32708
iRadimed Corp develops, manufactures, markets and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates majority revenue from United States.

iRadimed Headlines

No Headlines